Entrada Therapeutics
Aims to treat devastating diseases through the intracellular delivery of biologics.
Launch date
Employees
Market cap
€502m
Enterprise valuation
€134m (Public information from Sep 2024)
Share price
$15 TRDA
Boston Massachusetts (HQ)
Authorizing premium user...